FGEN and ALPMY Related Headlines

Go Back

Nov 27, 2020 02:02AM Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Oct 14, 2020 07:08AM FibroGen (FGEN) to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week
Oct 14, 2020 07:00AM FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2020 Reimagined
May 21, 2020 07:00AM European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat
May 20, 2020 10:00PM European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat

FGEN and ALPMY Related Press Releases

Go Back

Nov 27, 2020 02:02AM Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Oct 14, 2020 07:00AM FibroGen to Present New Efficacy and Safety Analyses from Roxadustat Global Phase 3 Program at American Society of Nephrology Kidney Week 2020 Reimagined
May 21, 2020 07:00AM European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat
May 20, 2020 10:00PM European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat

FGEN and ALPMY Related SEC Filings

Go Back